Rhenman & Partners Asset Management Ab Merck & Co., Inc. Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

A detailed history of Rhenman & Partners Asset Management Ab transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 241,000 shares of MRK stock, worth $24.1 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares

241,000

Previous 175,000 37.71%

Holding current value

$24.1 Million

Previous $21.7 Million 26.32%

% of portfolio

2.28%

Previous 2.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$111.15 - $128.97 $7.34 Million - $8.51 Million	66,000 Added 37.71%	241,000 $27.4 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $5.39 Million - $5.78 Million	-43,500 Reduced 19.91%	175,000 $21.7 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $8.04 Million - $9.37 Million	71,000 Added 48.14%	218,500 $28.8 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $4.26 Million - $4.63 Million	-42,500 Reduced 22.37%	147,500 $16.1 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $14.9 Million - $16.6 Million	145,000 Added 322.22%	190,000 $19.6 Million
Q3 2023 Nov 09, 2023	SELL	$102.95 - $114.33 $14.9 Million - $16.6 Million	-145,000 Reduced 76.32%	45,000 $4.63 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $5.54 Million - $6.04 Million	-51,000 Reduced 21.16%	190,000 $21.9 Million
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $2.68 Million - $2.99 Million	26,000 Added 12.09%	241,000 $25.6 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $4.23 Million - $4.75 Million	-50,000 Reduced 18.87%	215,000 $21.8 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $3.34 Million - $3.79 Million	40,000 Added 17.78%	265,000 $24.2 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $5.51 Million - $6.18 Million	-75,000 Reduced 25.0%	225,000 $18.5 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $2.11 Million - $2.33 Million	30,000 Added 11.11%	300,000 $23.3 Million
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $5.1 Million - $6 Million	-74,020 Reduced 21.52%	270,000 $20.8 Million
Q4 2020 Jan 19, 2021	BUY	$71.77 - $79.65 $13.2 Million - $14.7 Million	184,020 Added 115.01%	344,020 $28.1 Million
Q2 2020 Jul 16, 2020	SELL	$70.42 - $80.13 $352,100 - $400,650	-5,000 Reduced 3.03%	160,000 $12.4 Million
Q1 2020 Apr 16, 2020	BUY	$63.36 - $87.82 $316,800 - $439,099	5,000 Added 3.13%	165,000 $12.7 Million
Q4 2019 Jan 17, 2020	SELL	$77.58 - $87.54 $4.27 Million - $4.81 Million	-55,000 Reduced 25.58%	160,000 $14.6 Million
Q3 2019 Oct 16, 2019	BUY	$76.08 - $82.93 $16.4 Million - $17.8 Million	215,000 New	215,000 $18.1 Million
Q4 2017 Jan 19, 2018	SELL	$51.62 - $61.64 $4.65 Million - $5.55 Million	-90,000 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$58.67 - $63.13 $5.28 Million - $5.68 Million	90,000	90,000 $5.76 Million

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account

Rhenman & Partners Asset Management Ab Merck & Co., Inc. Transaction History